Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas
Alexander M.M. Eggermont(University Medical Center Utrecht), Ferdy J. Lejeune, Harald J. Hoekstra(University Medical Center Groningen), Heimen Schraffordt Koops, Christoph Kettelhack, Omgo E. Nieweg, Bin B. R. Kroon, Peter M. Schlag(Charité - Universitätsmedizin Berlin), Isaac Meller, Joseph M. Klausner, Jean‐Claude Pector(Dutch Cancer Society), Albertus N. van Geel, Danielle Líénard(University Hospital of Lausanne), G Ben-Ari
Cited by 458
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k